The Global Cough Syrup Market size is expected to reach $7.8 billion by 2026, rising at a market growth of 5.8% CAGR during the forecast period. Cough syrups are liquid medication, which is used to cure cough that causes an upper respiratory tract infection (URTI). Furthermore, a cough could be among the symptoms of many chronic diseases like asthma. Majorly, cough syrups are available in two types, one is for dry cough and another one is for a chesty cough. There are many cases in which cough syrups don’t work perfectly for many people. But there are many people who find it effective for their cough related problems. These cough syrups are sweet liquid medication that helps in relieving the cough.
Increasing air pollution is causing various health issues especially respiratory problems, which can lead to URTI, cough & common cold, thereby contributing to the growth of the cough syrup market. Air pollution is among the major cause of chronic respiratory problems. According to a report by the Forum of International Respiratory Societies (FIRS), factors like indoor air pollution from burning fuels, smoking tobacco, and pollution emitted from vehicles & industries are the prime aspects causing major respiratory issues.
Cough syrups witnesses a surge in demand due to their wide usage for curing common cold, URTI, and hay fever. Moreover, the increasing disposable income of people in emerging nations will also contribute to the rising growth of the cough syrups market. In addition, the growing geriatric population will also open various growth prospects for the market.
Based on Product, the market is segmented into Cough Suppressants, Combination Medications and Expectorants. On the basis of product type, the cough suppressants/antitussives market segment acquired the highest share in the market in 2019 and will witness the same trend during the forecast period. The general availability of dextromethorphan at medical stores or pharmacies is likely to drive the growth of the market.
Based on Age Group, the market is segmented into Adult and Pediatric. Based on age group, the adult segment will garner the highest growth rate over the forecast period. It is because of the increasing geriatric population and rising respiratory problems among adults. Moreover, this growth is driven majorly because cough syrups are mostly prescribed to the adult age group by the doctors however the pediatric population should not be offered the OTC cough syrups without getting a prescription by a doctor.
| Report Attribute | Details |
|---|---|
| Market size value in 2019 | USD 5.8 Billion |
| Market size forecast in 2026 | USD 7.8 Billion |
| Base Year | 2019 |
| Historical Period | 2016 to 2018 |
| Forecast Period | 2020 to 2026 |
| Revenue Growth Rate | CAGR of 5.8% from 2020 to 2026 |
| Number of Pages | 183 |
| Number of Tables | 340 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Product, Age Group, Distribution Channel, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online. The Retail Pharmacy market dominated the Global Cough Syrup Market by Distribution Channel in 2019, growing at a CAGR of 4 % during the forecast period. The Hospital Pharmacy market is showcasing a CAGR of 4.6% during (2020 - 2026).
Free Valuable Insights: Global Cough Syrup Market to reach a market size of $7.8 Billion by 2026
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2019, the Asia-Pacific region procured the largest revenue share in the market. It is also anticipated that this region will continue its dominance during the forecast period. It is due to the easy availability of cough syrups at pharmacies or medical stores, increasing in the geriatric population, and lesser strict rules & regulations related to the abuse of cough & cold medicines in the region.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Novartis AG, Merck Group, Johnson and Johnson, GlaxoSmithKline PLC (GSK), The Procter and Gamble Company, Reckitt Benckiser Group PLC, Abbott Laboratories, Sanofi S.A., and Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC).
By Product
By Age Group
By Distribution Channel
By Geography
The global cough syrup market size is expected to reach $7.8 billion by 2026.
Increasing prevalence of respiratory problems are driving the market in coming years, however, misuse of cough syrups and strict rules & regulation by the government have limited the growth of the market.
Pfizer, Inc., Novartis AG, Merck Group, Johnson and Johnson, GlaxoSmithKline PLC (GSK), The Procter and Gamble Company, Reckitt Benckiser Group PLC, Abbott Laboratories, Sanofi S.A., and Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC).
The Cough Suppressants market dominated the Global Cough Syrup Market by Product in 2019, growing at a CAGR of 4.2 % during the forecast period.
The Asia Pacific market dominated the Global Cough Syrup Market by Region in 2019.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 